S E Rivkin
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Sarcoma Diagnosis and Treatment 2
- Pleural and Pulmonary Diseases 1
-
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- Tate Thigpen (2 shared papers)R Bottomley (2 shared papers)Walter J. Stuckey (2 shared papers)Lance K. Heilbrun (1 shared paper)Daniel E. Lehane (1 shared paper)Terence N. Moore (1 shared paper)Robert B. Livingston (1 shared paper)Thomas R. Fleming (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Internal Medicine (1 paper)Blood (1 paper)Annals of Oncology (1 paper)PubMed (6 papers)
- Partner nations
- United States
In The Last Decade
S E Rivkin
12 papers receiving 796 citations
Peers
Comparison fields: 5 of 43
- Oncology 198
- Hematology 99
- Pulmonary and Respiratory Medicine 205
- Surgery 249
- Public Health, Environmental and Occupational Health 119
Countries citing papers authored by S E Rivkin
This map shows the geographic impact of S E Rivkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S E Rivkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S E Rivkin more than expected).
Fields of papers citing papers by S E Rivkin
This network shows the impact of papers produced by S E Rivkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S E Rivkin. The network helps show where S E Rivkin may publish in the future.
Co-authors
The 25 scholars most cited alongside S E Rivkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 251 | |
| 2 | 1978 | 203 | |
| 3 | 1989 | 129 | |
| 4 | Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. | 1980 | 102 |
| 5 | 1986 | 74 | |
| 6 | 1987 | 74 | |
| 7 | 1991 | 45 | |
| 8 | Phase II evaluation of bisantrene in patients with renal cell carcinoma. | 1982 | 10 |
| 9 | Vinblastine, bleomycin, and cis-dichlorodiammineplatinum(II) in disseminated testicular cancer: preliminary report of a Southwest Oncology Group Study. | 1980 | 9 |
| 10 | Palliation in malignant pleural effusion. | 1975 | 7 |
| 11 | Phase II trial of amsacrine in pancreatic carcinoma: a Southwest Oncology Group study. | 1984 | 3 |
| 12 | Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study. | 1982 | 2 |
| 13 | 2026 | 0 |
About S E Rivkin
S E Rivkin is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Oncology, Hematology and Cancer Research, having authored 13 papers that have together received 909 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (2 papers), Sarcoma Diagnosis and Treatment (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Pleural and Pulmonary Diseases (1 paper), Testicular diseases and treatments (1 paper), Esophageal Cancer Research and Treatment (1 paper), Lung Cancer Research Studies (1 paper) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Oncology (198 citations), Hematology (99 citations), Pulmonary and Respiratory Medicine (205 citations), Surgery (249 citations) and Public Health, Environmental and Occupational Health (119 citations). S E Rivkin has collaborated with scholars based in United States. Frequent co-authors include Tate Thigpen, R Bottomley, Walter J. Stuckey, Lance K. Heilbrun, Daniel E. Lehane, Terence N. Moore, Robert B. Livingston, Thomas R. Fleming, Zwi Steiger and Sarah A. Taylor. Their work appears in journals such as Journal of Clinical Oncology, Annals of Internal Medicine, Blood, Annals of Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.